Cinnamaldehyde alleviates pulmonary hypertension by affecting vascular remodeling through the TLR4/NF-kB/HIF-1a pathway
CA alleviates PAH by inhibiting the TLR4/NF-kB/HIF-1a pathway and suppressing vascular remodeling, suggesting its potential as a therapeutic agent for PAH.
Authors
- Chunhe Wang (ORCID: https://orcid.org/0000-0002-9598-8968)
- Zhiyong Yang (ORCID: https://orcid.org/0000-0002-2806-1214)
- Bingbing Fan (ORCID: https://orcid.org/0000-0002-0680-9316)
- Zhigang Tian (ORCID: https://orcid.org/0000-0002-5512-6378)
- Wenxin Zhang (ORCID: https://orcid.org/0000-0002-4178-3780)
- Jinbo Zhang (ORCID: https://orcid.org/0000-0001-8287-3259)
Institutions
- Shandong University of Traditional Chinese Medicine (CN)
- College of Tourism (BG)
- Yantaishan Hospital (CN)
Publication Details
- Journal
- Clinical and Experimental Hypertension
- Published
- 2025-04-02
- DOI
- https://doi.org/10.1080/10641963.2025.2486829
- Citations
- 6
- Primary Topic
- Pulmonary Hypertension Research and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 9.11